Literature DB >> 24664542

Two Chinese pedigrees for adenomatous polyposis coli: new mutations at codon 1309 and predisposition to phenotypic variations.

Dai-Xiang Liao1, Bing Li, Xue-Mei Du, Jun-Hui Yu, Hong Chang, Zhi-Qiang Wu, Hao-Jie Hao, You-Xin Wang, Wei-Dong Han, Shu-Jun Cheng, Cheng-Hua Luo.   

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant inherited disease caused by a mutation in the adenomatous polyposis coli (APC) gene. Some studies have attempted to correlate mutations at codon 1309 with classic FAP (≥100 colorectal polyps). We report two Chinese FAP pedigrees with new frameshift mutations at codon 1309, in which affected individuals manifest phenotypic variations. Comprehensive physical examinations were performed for all living individuals and the medical data of deceased patients were collected. Screening of the APC and human mutY homolog (MUTYH) genes for germline mutations was conducted by direct polymerase chain reaction (PCR) sequencing. In two pedigrees, a heterozygous deletion in exon 16 of the APC gene was present in all FAP patients but absent in the unaffected individuals. There were no changes to the MUTYH gene. The first pedigree, with a new frameshift mutation at c.3926_3930 del AAAAG (p. Glu1309Aspfs X4), exhibited obvious differences in the polyp number such that the proband manifested only three colorectal polyps, whereas another patients showed the symptoms of classic FAP. The second pedigree, also traced a new mutation at c.3922_3925 del AAAG (p. Glu1309Argfs X11). Although all of the patients presented with classic polyposis, one of them exhibited a delayed onset of colorectal cancer in his 50s. Two novel mutations at codon 1309 in two Chinese families suffering from FAP could enrich the germline mutation spectrum of the APC gene. Families of individuals might manifest different phenotypes, even with an identical codon 1309 mutation, unlike in previous studies.

Entities:  

Mesh:

Year:  2014        PMID: 24664542     DOI: 10.1007/s10689-014-9713-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  48 in total

1.  Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes.

Authors:  R Houlston; M Crabtree; R Phillips; M Crabtree; I Tomlinson
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 4.  Gardner syndrome: skin manifestations, differential diagnosis and management.

Authors:  Edward Juhn; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2010       Impact factor: 7.403

5.  Novel insertion mutation p.Asp610GlyfsX23 in APC gene causes familial adenomatous polyposis in Chinese families.

Authors:  Guibo Song; Yufeng Yuan; Fang Zheng; Na Yang
Journal:  Gene       Date:  2013-01-03       Impact factor: 3.688

6.  Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes.

Authors:  M D Crabtree; I P M Tomlinson; S V Hodgson; K Neale; R K S Phillips; R S Houlston
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation.

Authors:  F M Giardiello; A J Krush; G M Petersen; S V Booker; M Kerr; L L Tong; S R Hamilton
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

8.  Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer.

Authors:  R A Barnetson; L Devlin; J Miller; S M Farrington; S Slater; A C Drake; H Campbell; M G Dunlop; M E Porteous
Journal:  Clin Genet       Date:  2007-10-22       Impact factor: 4.438

9.  Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.

Authors:  M D Crabtree; C Fletcher; M Churchman; S V Hodgson; K Neale; R K S Phillips; I P M Tomlinson
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes.

Authors:  R J Scott; R van der Luijt; M Spycher; J L Mary; A Müller; T Hoppeler; M Haner; H Müller; S Martinoli; P L Brazzola
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

View more
  4 in total

1.  Identification a nonsense mutation of APC gene in Chinese patients with familial adenomatous polyposis.

Authors:  Haishan Li; Lingling Zhang; Quan Jiang; Zhenwang Shi; Hanxing Tong
Journal:  Exp Ther Med       Date:  2017-02-14       Impact factor: 2.447

2.  Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort.

Authors:  Nikhat Khan; Anuja Lipsa; Gautham Arunachal; Mukta Ramadwar; Rajiv Sarin
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

3.  Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).

Authors:  Faranak Ghadamyari; Mohammad Mehdi Heidari; Sirous Zeinali; Mehri Khatami; Shahin Merat; Hamideh Bagherian; Leili Rejali; Farzaneh Ghasemi
Journal:  J Clin Lab Anal       Date:  2021-03-26       Impact factor: 2.352

4.  A novel APC mutation identified in a large Chinese family with familial adenomatous polyposis and a brief literature review.

Authors:  Minghui Pang; Yijun Liu; Xiaolin Hou; Jialiang Yang; Xuelai He; Nengyi Hou; Peixi Liu; Luo Liang; Junwen Fu; Kang Wang; Zimeng Ye; Bo Gong
Journal:  Mol Med Rep       Date:  2018-06-05       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.